Breast cancer metastasis: markers and models
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view--it suggests that metastatic capacity is a late, acquired event in tumorigenesis. Others have proposed the idea that breast cancer is intrinsically a systemic disease. New molecular technologies, such as DNA microarrays, support the idea that metastatic capacity might be an inherent feature of breast tumours. These data have important implications for prognosis prediction and our understanding of metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune cells were shown to both enhance and inhibit malignant cells proliferation, migration, and metastasis [125-128].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [125]
In the citing paper
“Chemical gradients play an important role in tumor cell invasion of metastatic cancer [195,196] as it significantly directs the migration and differentiation of tumor cells.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [196]
In the citing paper
“Metastasis is the leading cause of death from breast cancer1, 37-39.”
From Liposomal Formulation of HIF-1α Inhibitor Echinomycin Eliminates Established Metastases of Triple-negative Breast Cancer (2020) · cites this paper as [1]
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“ERBB2 is overexpressed due to gene amplification in 15–30% of human breast cancer”
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Research works printed but not linked: 2
- Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumour embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
- Leighton, J. Inherent malignancy of cancer cells possibly limited by genetically differing cells in the same tumour. Acta Cytol. 9, 138–140 (1965).
Cited by
Items 201–300 of 1,003
Athymic Nude Mice as an Experimental Model for Cancer Treatment
Szadvári, I., Križanová, O., & Babula, P. (2016) · Physiological Research · doi:10.33549/physiolres.933526 · Cited by 131
“In the intracardial model, the most frequent metastatic sites are determined by the tumor type; e.g. bone and lung in prostatic tumors (Bubendorf et al. 2000) or lung, bone, and liver in breast tumors (Weigelt et al. 2005).”
Li, Z., Li, Y., Li, Y., Ren, K., Li, X., Han, X., & Wang, J. (2017) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21933 · Cited by 129
Liu, Q., Hodge, J., Wang, J., Wang, Y., Wang, L., Singh, U. P., Li, Y., Yao, Y., Wang, D., Ai, W., et al. (2020) · Theranostics · doi:10.7150/thno.45395 · Cited by 133
CCR7 as a therapeutic target in Cancer
Salem, A., Alamir, M. B., Mroueh, R., Basheer, H. A., & Afarinkia, K. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188499 · Cited by 155
Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients
Xi, G., Guo, W., Kang, D., Ma, J., Fu, F., Qiu, L., Zheng, L., He, J., Fang, N., Chen, J., et al. (2021) · Theranostics · doi:10.7150/thno.55921 · Cited by 138
“The accumulation of numerous large-scale SHG-TPEF images and co-registered H&E images from the training cohort allowed us to recognize 8 major TACSs (Figure 1C, Figures 2-3), in a manner like how up to 17 histopathological subtypes were identified as biomarkers from H&E images [1].”
Injectable Sustained Release Microparticles of Curcumin: A New Concept for Cancer Chemoprevention
Shahani, K., Swaminathan, S. K., Freeman, D., Blum, A., Ma, L., & Panyam, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4362 · Cited by 128
“The lungs and brain are common sites of metastases in breast cancer patients (39, 40).”
Host genetics influence tumour metastasis
Hunter, K. W. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1803 · Cited by 142
David, M., Wannecq, E., Descotes, F., Jansen, S., Deux, B., Ribeiro, J., Serre, C.-M., Grès, S., Bendriss-Vermare, N., Bollen, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009741 · Cited by 120
Walsh, C., Tanjoni, I., Uryu, S., Tomar, A., Nam, J.-O., Luo, H., Phillips, A., Patel, N., Kwok, C., McMahon, G., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.10.11433 · Cited by 124
Ye, T., Xiong, Y., Yan, Y., Xia, Y., Song, X., Liu, L., Li, D., Wang, N., Zhang, L., Zhu, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085887 · Cited by 139
Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
Zhu, Y., Tian, Y., Du, J., Hu, Z., Yang, L., Liu, J., & Gu, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037823 · Cited by 131
Hollern, D. P., Honeysett, J., Cardiff, R. D., & Andrechek, E. R. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00737-14 · Cited by 130
Tumor size and survival in breast cancer—a reappraisal
Foulkes, W. D., Reis-Filho, J. S., & Narod, S. A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.39 · Cited by 127
“The eventual result would be the emergence of subclones with the ability to metastasize and colonize other anatomic sites”
BackgroundKim, H.-Y., Lee, K., Kim, S., Kwon, Y., Chun, Y., & Choi, H. (2016) · Oncotarget · doi:10.18632/oncotarget.11560 · Cited by 124
“The developed markers that have true prognostic use for patients with breast cancer include the level of urokinase-type plasminogen activator/plasminogen activator inhibitor 1 protein (uPA/PAI1), steroid-receptor expression, and epidermal growth factor receptor 2 (ERBB2) gene amplification and protein expression [3].”
Li, X., Xiang, J., Wang, J., Li, J., Wu, F., & Li, M. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.2973148 · Cited by 135
Ateeq, B., Unterberger, A., Szyf, M., & Rabbani, S. A. (2008) · Neoplasia · doi:10.1593/neo.07947 · Cited by 120
Insights into the Link Between Obesity and Cancer
Ackerman, S. E., Blackburn, O. A., Marchildon, F., & Cohen, P. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0263-x · Cited by 132
USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis
Ma, A., Tang, M., Zhang, L., Wang, B., Yang, Z., Liu, Y., Xu, G., Wu, L., Jing, T., Xu, X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0590-8 · Cited by 121
Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol
Androic, I., Krämer, A., Yan, R., Rödel, F., Gätje, R., Kaufmann, M., Strebhardt, K., & Yuan, J. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-391 · Cited by 121
Circulating Nucleic Acids in Plasma and Serum: Recent Developments
Gahan, P. B., & Swaminathan, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.050 · Cited by 121
Roukos, D. H., Murray, S. J., & Briasoulis, E. C. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.3.3994 · Cited by 126
Small molecules with big effects: The role of the microRNAome in cancer and carcinogenesis
Koturbash, I., Zemp, F. J., Pogribny, I. P., & Kovalchuk, O. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.05.006 · Cited by 127
Wei, X., Luo, Q., Sun, L., Li, X., Zhu, H., Guan, P., Wu, M., Luo, K., & Gong, Q. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b02006 · Cited by 119
Chang, A., Le, C. P., Walker, A. K., Creed, S. J., Pon, C. K., Albold, S., Carroll, D., Halls, M. L., Lane, J. R., Riedel, B., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.06.011 · Cited by 110
Nanoparticles for imaging and treatment of metastatic breast cancer
Mu, Q., Wang, H., & Zhang, M. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1208650 · Cited by 124
Qu, H., Zhou, M., Yan, Z., Wang, H., Rustgi, V. K., Zhang, S., Gevaert, O., & Metaxas, D. N. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00225-9 · Cited by 117
“We hypothesize that the models trained using breast cancer data can also predict important gene mutations and pathway activities in lung and liver cancers since they are two common sites for the breast cancer metastatic spread 34 .”
MethodRGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy
Sheikh, A., Md, S., & Kesharwani, P. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.10.028 · Cited by 120
Leth‐Larsen, R., Lund, R. R., Hansen, H. V., Lænkholm, A., Tarin, D., Jensen, O. N., & Ditzel, H. J. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800061-mcp200 · Cited by 129
Tumor-Targeted Drug Delivery with Aptamers
Zhang, Y., Hong, H., & Cai, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797189547 · Cited by 117
Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model
Yang, F., Hu, M., Lei, Q., Xia, Y., Zhu, Y., Song, X., Li, Y., Jie, H., Liu, C., Xiong, Y., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.63 · Cited by 122
CYLD: A Deubiquitination Enzyme with Multiple Roles in Cancer
Massoumi, R. (2011) · Future Oncology · doi:10.2217/fon.10.187 · Cited by 124
“Breast cancer Breast cancer is a highly heterogeneous disease, representing several distinct histological and genetic subtypes; at the molecular level, a vast number of genetic alterations have been identified [70].”
BackgroundKLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival
Hatami, R., Sieuwerts, A. M., Izadmehr, S., Yao, Z., Qiao, R., Papa, L., Look, M. P., Smid, M., Ohlseen, J., Levine, A. C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004688 · Cited by 125
The steroidal glycoalkaloids solamargine and solasonine in Solanum plants
Al-Sinani, S. S., & Eltayeb, E. A. (2017) · South African Journal of Botany · doi:10.1016/j.sajb.2017.06.002 · Cited by 124
Graph attention network for link prediction of gene regulations from single-cell RNA-sequencing data
Chen, G., & Liu, Z. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac559 · Cited by 135
Guo, C., Yu, H., Feng, B., Gao, W., Yan, M., Zhang, Z., Li, Y., & Liu, S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.054 · Cited by 116
Brackenbury, W. J., Djamgoz, M. B. A., & Isom, L. L. (2008) · The Neuroscientist · doi:10.1177/1073858408320293 · Cited by 114
Chemokines and chemokine receptors: A new strategy for breast cancer therapy
Liu, H., Yang, Z., Lü, W., Chen, Z., Chen, L., Han, S., Wu, X. Y., Cai, T., & Cai, Y. (2020) · Cancer Medicine · doi:10.1002/cam4.3014 · Cited by 128
Watson, M. A., Ylagan, L. R., Trinkaus, K. M., Gillanders, W. E., Naughton, M. J., Weilbaecher, K. N., Fleming, T. P., & Aft, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0024 · Cited by 127
Xu, Y., Zhang, S., Liao, X., Li, M., Chen, S., Li, X., Wu, X., Yang, M., Tang, M., Hu, Y., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01394-8 · Cited by 124
Zhao, X., Hu, J.-Y., Tang, J., Yi, W., Zhang, M., Deng, R., Mai, S., Weng, N., Wang, R., Liu, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1705-z · Cited by 113
Identification of brain- and bone-specific breast cancer metastasis genes
Klein, A., Olendrowitz, C., Schmutzler, R., Hampl, J. A., Schlag, P. M., Maass, N., Arnold, N., Wessel, R., Ramser, J., Meindl, A., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.017 · Cited by 113
Baicalein inhibits the migration and invasive properties of human hepatoma cells
Chiu, Y.-W., Lin, T.-H., Huang, W.-S., Teng, C.-Y., Liou, Y., Kuo, W., Lin, W.-L., Huang, H.-I., Tung, J.-N., Huang, C., et al. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.07.008 · Cited by 119
Injectable Hexapeptide Hydrogel for Localized Chemotherapy Prevents Breast Cancer Recurrence
Qi, Y., Min, H., Mujeeb, A., Zhang, Y., Han, X., Zhao, X., Anderson, G. J., Zhao, Y., & Nie, G. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b19258 · Cited by 113
Sandiford, O. A., DONNELLY, R. J., El-Far, M. H., Burgmeyer, L. M., Sinha, G., Pamarthi, S. H., Sherman, L. S., Ferrer, A. I., DeVore, D. E., Patel, S. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2434 · Cited by 125
Wang, J., Liu, Q., Xie, H., Yang, Z., & Zhou, H. (2021) · Cancers · doi:10.3390/cancers13040661 · Cited by 106
Zhou, H., Tang, D., Yu, Y., Zhang, L., Wang, B., Karges, J., & Xiao, H. (2023) · Nature Communications · doi:10.1038/s41467-023-40826-5 · Cited by 124
“Based on the metastatic nature of 4T1 breast cancer tumors 61 , various metastases were observed in the lungs of the untreated animal model.”
BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10
Gong, C., Qu, S., Lv, X.-B., Liu, B., Tan, W., Nie, Y., Su, F., Liu, Q., Yao, H., & Song, E. (2014) · Nature Communications · doi:10.1038/ncomms6406 · Cited by 119
Huggins, D. N., LaRue, R. S., Wang, Y., Knutson, T. P., Xu, Y., Williams, J. W., & Schwertfeger, K. L. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0101 · Cited by 110
The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis
Mei, W., Lin, X., Kapoor, A., Gu, Y. J., Zhao, K., & Tang, D. (2019) · Cancers · doi:10.3390/cancers11040434 · Cited by 115
Wang, J.-S., Wang, F.-B., Zhang, Q.-G., Shen, Z.-Z., & Shao, Z.-M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0162 · Cited by 109
“and common causes of death for patients with cancer (1).”
BackgroundZhang, L., Xu, L., Zhang, F., & Vlashi, E. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1241929 · Cited by 112
Kersten, K., Coffelt, S. B., Hoogstraat, M., Verstegen, N. J. M., Vrijland, K., Ciampricotti, M., Doornebal, C. W., Hau, C.-S., Wellenstein, M. D., Salvagno, C., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1334744 · Cited by 109
The roles of the Hippo pathway in cancer metastasis
van Rensburg, H. J. J., & Yang, X. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.08.004 · Cited by 113
Tumor Spheroid-Based Migration Assays for Evaluation of Therapeutic Agents
Vinci, M., Box, C., Zimmermann, M., & Eccles, S. A. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-311-4_16 · Cited by 106
Breast cancer brain metastasis: molecular mechanisms and directions for treatment
Pedrosa, R. M. S. M., Mustafa, D. A. M., Soffietti, R., & Kros, J. M. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy044 · Cited by 114
FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression
Sun, R., Xie, H.-Y., Qian, J.-X., Huang, Y.-N., Yang, F., Zhang, F.-L., Shao, Z., & Li, D. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3647 · Cited by 107
Chen, Y., Lu, B., Yang, Q., Fearns, C., Yates, J. R., & Lee, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2515 · Cited by 109
Emerging strategies in cancer therapy combining chemotherapy with immunotherapy
Luo, Q., Zhang, L., Luo, C., & Jiang, M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.017 · Cited by 104
Pangeni, R. P., Channathodiyil, P., Huen, D. S., Eagles, L., Johal, B. K., Pasha, D., Hadjistephanou, N., Nevell, O., Davies, C. L., Adewumi, A. I., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0089-x · Cited by 106
“However, prediction of site-specific metastasis remains poor [36].”
Liu, P., Tsai, J., Charles, A. L., Hwang, J., Chou, S., Ping, Y., Lin, F., Chen, Y., Hung, C.-Y., Chen, W., et al. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900550 · Cited by 105
Salem, O., Erdem, N., Jung, J., Münstermann, E., Wörner, A., Wilhelm, H., Wiemann, S., & Körner, C. (2016) · BMC Genomics · doi:10.1186/s12864-016-2869-x · Cited by 115
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
Paschall, A. V., & Liu, K. (2016) · Journal of Visualized Experiments · doi:10.3791/54040 · Cited by 105
The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis
Liang, Y., Xu, X., Wang, T., Li, Y., You, W., Fu, J. H., Liu, Y., Jin, S., Ji, Q., Zhao, W. M., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.325 · Cited by 107
“38 Chang et al. reported that EGFR enhances prostate cancer bone metastasis by decreasing miR-1 expression and increasing TWIST1 expression in vitro and in nude mice, and decreased miR-1 levels associate with enhanced EGFR and TWIST1 expression in a cohort of human prostate cancer specimens.”
Sun, J., Chen, X., Wang, Z., Guo, M., Shi, H., Wang, X., Cheng, L., & Zhou, M. (2015) · Scientific Reports · doi:10.1038/srep16553 · Cited by 104
Rhodes, L. V., Tate, C. R., Segar, H. C., Burks, H. E., Phamduy, T. B., Hoang, V., Elliott, S., Gilliam, D., Pounder, F. N., Anbalagan, M., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2979-6 · Cited by 101
“Previously, development of many new therapies was centered on targeting the primary tumor; however, the majority of breast cancer deaths are due to distant metastasis [41].”
BackgroundAnoikis, Initiated by Mcl-1 Degradation and Bim Induction, Is Deregulated during Oncogenesis
Woods, N. T., Yamaguchi, H., Lee, F. Y., Bhalla, K. N., & Wang, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3148 · Cited by 107
“Despite recent advances in early detection and new therapeutic options for cancer patients, metastatic progression is attributed to 90% of human cancer fatalities (32).”
MicroRNA‐206 Is Associated With Invasion and Metastasis of Lung Cancer
Wang, X., Ling, C., Bai, Y., & Zhao, J. (2011) · The Anatomical Record · doi:10.1002/ar.21287 · Cited by 104
Mitra, S. K., Lim, S.-T., Chi, A., & Schlaepfer, D. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209482 · Cited by 103
A systems biology view of cancer
Laubenbacher, R., Hower, V., Jarrah, A., Torti, S. V., Shulaev, V., Mendes, P., Torti, F. M., & Akman, S. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.06.001 · Cited by 101
Second harmonic generation reveals matrix alterations during breast tumor progression
Burke, K. A., Tang, P., & Brown, E. B. (2012) · Journal of Biomedical Optics · doi:10.1117/1.jbo.18.3.031106 · Cited by 102
Giordano, A., Giuliano, M., Laurentiis, M. D., Arpino, G., Jackson, S. A., Handy, B. C., Ueno, N. T., Andreopoulou, E., Alvarez, R. H., Valero, V., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr434 · Cited by 110
“However, 40% of patients initially presenting with localized disease eventually experience progression to MBC and die of their disease [2].”
BackgroundHagerling, C., Velozo, H. G., Salari, K., Wang, C., Lin, C., Robles, I., van Gogh, M., Dejmek, A., Jirström, K., & Werb, Z. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907660116 · Cited by 120
Kondaveeti, Y., Reed, I. K. G., & White, B. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.025 · Cited by 111
Xi, C., Hu, Y., Buckhaults, P., Moskophidis, D., & Mivechi, N. F. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.377481 · Cited by 101
dos Santos, P. B., Zanetti, J. S., Ribeiro‐Silva, A., & Beltrão, E. I. U. F. D. P. (2012) · Diagnostic Pathology · doi:10.1186/1746-1596-7-104 · Cited by 102
Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion
Zhang, T., Li, J., Dong, Y., Zhai, D., Lai, L., Dai, F., Deng, H., Chen, Y., Liu, M., & Yi, Z. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2175-5 · Cited by 101
“cancer metastasis poses a predominant threat to cancerrelated mortality [2].”
BackgroundOrthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.
Kocatürk, B., & Versteeg, H. H. (2015) · Journal of Visualized Experiments · doi:10.3791/51967 · Cited by 103
Targeting Intracellular Oncoproteins with Antibody Therapy or Vaccination
Guo, K., Li, J., Tang, J. P., Tan, C. P. B., Hong, C. W., Al-Aidaroos, A. Q., Varghese, L., Huang, C., & Zeng, Q. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002296 · Cited by 99
Ward, C., Meehan, J., Mullen, P., Supuran, C., Dixon, J. M., Thomas, J. S., Winum, J.-Y., Lambin, P., Dubois, L., Pavathaneni, N.-K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4498 · Cited by 96
Arya, A. D., Hallur, P. M., Karkisaval, A. G., Gudipati, A., Rajendiran, S., Dhavale, V., Ramachandran, B., Aravindakshan, J., Gundiah, N., & Chaubey, A. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b06309 · Cited by 103
A review of chemical gradient systems for cell analysis
Somaweera, H., Ibraguimov, A., & Pappas, D. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.12.008 · Cited by 98
Demont, Y., Corbet, C., Page, A., Ataman-Önal, Y., Choquet-Kastylevsky, G., Fliniaux, I., Le Bourhis, X., Toillon, R.-A., Bradshaw, R. A., & Hondermarck, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211714 · Cited by 86
Liu, Y., Cao, W., Zhang, B., Liu, Y., Wang, Z., Wu, Y., Yu, X., Zhang, X., Ming, P., Zhou, G., et al. (2013) · Scientific Reports · doi:10.1038/srep03098 · Cited by 98
Hedegaard, M. A. B., Krafft, C., Ditzel, H. J., Johansen, L. E., Hassing, S., & Popp, J. (2010) · Analytical Chemistry · doi:10.1021/ac902717d · Cited by 104
2D protrusion but not motility predicts growth factor–induced cancer cell migration in 3D collagen
Meyer, A. S., Hughes-Alford, S. K., Kay, J. E., Castillo, A., Wells, A., Gertler, F. B., & Lauffenburger, D. A. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201201003 · Cited by 94
Cai, X., Liu, J., Liew, W. H., Duan, Y., Geng, J., Thakor, N., Yao, K., Liao, L.-D., & Liu, B. (2017) · Materials Chemistry Frontiers · doi:10.1039/c7qm00056a · Cited by 95
Rigiracciolo, D. C., Santolla, M. F., Lappano, R., Vivacqua, A., Cirillo, F., Galli, G. R., Talia, M., Muglia, L., PELLEGRINO, M. A., Nohata, N., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1056-8 · Cited by 105
Li, Q., Yang, H., Wang, P., Liu, X., Lv, K., & Ye, M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03369-9 · Cited by 110
Discovery of biomarkers for gastric cancer: A proteomics approach
Lin, L., Huang, H., & Juan, H. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.03.046 · Cited by 102
Cancer nanotheranostics: Strategies, promises and impediments
Chowdhury, M. R., Schumann, C., Bhakta-Guha, D., & Guha, G. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.035 · Cited by 106
Vitolo, M. I., Weiss, M. B., Szmacinski, M., Tahir, K., Waldman, T., Park, B. H., Martin, S. S., Weber, D. J., & Bachman, K. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1067 · Cited by 95
“Although metastasis is the cause of 90% of human cancer deaths (27), the metastatic process presents numerous challenges to tumor cells, including apoptosis that results from detachment (anoi-”
Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy
Yu, J., Zhou, B., Zhang, S., Yin, H., Sun, L., Pu, Y., Zhou, B., Sun, Y., Li, X., Fang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35580-z · Cited by 104
Cao, H., Zhang, Z., Zhao, S., He, X., Yu, H., Yin, Q., Zhang, Z., Gu, W., Chen, L., & Li, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.015 · Cited by 95
Baldwin, R. M., Haghandish, N., Daneshmand, M., Amin, S., Paris, G., Falls, T. J., Bell, J. C., Islam, S., & Côté, J. (2014) · Oncotarget · doi:10.18632/oncotarget.3072 · Cited by 104
“Metastasis of the primary tumour to distant sites is the major cause of mortality amongst breast cancer patients [70].”
miR-429 inhibits migration and invasion of breast cancer cells in vitro
Ye, Z., Ma, G., Zhao, Y., Xiao, Y., Zhan, Y., Jing, C., Gao, K., Liu, Z., & Yu, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2759 · Cited by 94
“Breast cancer is likely to form distant metastases in lung, bone and liver (23).”
Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases
Siraj, M. A., Desestret, V., Antoine, M., Fromont, G., Huerre, M., Sanson, M., Camparo, P., Pichon, C., Planeix, F., Gonin, J., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-246 · Cited by 94
“Many of the processes that occur during metastatic tumor growth are similar to the processes in the primary parent tumors, as indicated by similar gene expression profiles of cells in the primary tumors and distant metastases in the same patient [8].”
Anti-cancer mechanisms of linalool and 1,8-cineole in non-small cell lung cancer A549 cells
Rodenak‐Kladniew, B., Castro, M. A., Crespo, R., Galle, M., & de Bravo, M. M. G. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05639 · Cited by 96
Reduction of metastasis using a non-volatile buffer
Ibrahim Hashim, A., Cornnell, H. H., Coelho Ribeiro, M. D. L., Abrahams, D., Cunningham, J., Lloyd, M., Martinez, G. V., Gatenby, R. A., & Gillies, R. J. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9415-7 · Cited by 92
Yavas, O., Aćimović, S. S., García-Guirado, J., Berthelot, J., Dobosz, P., Sanz, V., & Quidant, R. (2018) · ACS Sensors · doi:10.1021/acssensors.8b00305 · Cited by 98
β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion
Creed, S. J., Le, C. P., Hassan, M., Pon, C. K., Albold, S., Chan, K. T., Berginski, M. E., Huang, Z., Bear, J. E., Lane, J. R., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0655-3 · Cited by 105
Metadata
- Authors
- Weigelt, B., Peterse, J. L., & van't Veer, L. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- ORCID
- Weigelt, Britta
- Venue
- Nature Reviews Cancer
- Published
- 2005-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 591-602
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2004280628
- Semantic Scholar
- 3bd1490d7b6c8daa59bd35260c6c71e39d3d62fa
- Cited by
- 2,232
- References
- 112
- Citations by year
- 2026: 34 · 2025: 69 · 2024: 90 · 2023: 111 · 2022: 139 · 2021: 154 · 2020: 159 · 2019: 147 · 2018: 140 · 2017: 191 · 2016: 162 · 2015: 152 · 2014: 121 · 2013: 104 · 2012: 88
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- breast cancer, metastasis, prognostic factors, metastatic potential, lymph node metastasis, distant metastasis, carcinogenesis, DNA microarrays, systemic disease, metastasis model
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplasm Metastasis, Biomarkers, Tumor, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.